Ramipril Dosing Guidelines

Introduction to Ramipril Dosing

The American College of Cardiology recommends that the maximum dose of ramipril should be limited to 10mg daily for cardiovascular outcomes, as higher doses have not demonstrated additional benefits but may increase adverse effects 1
The 2013 ACC/AHA guideline for STEMI management recommends ramipril 2.5mg twice daily to start, titrating to 5mg twice daily (10mg total) as tolerated 2
The 2022 AHA/ACC/HFSA heart failure guideline specifically lists ramipril's target dose as 10mg once daily 3

The HOPE trial demonstrated that ramipril 10mg daily reduced cardiovascular death, MI, and stroke by 22% compared to placebo 1, 4
The dose-response curve for ACE inhibitors tends to flatten at higher doses, with minimal additional benefit above the recommended target dose 5

Higher doses of ramipril (>10mg) may increase the risk of adverse effects such as hypotension, renal dysfunction, hyperkalemia, cough, and angioedema 6

For patients with renal impairment (creatinine clearance <40 mL/min), the maximum dose of ramipril is 5mg daily for hypertension and 2.5mg twice daily for heart failure post-MI, although the specific citation for this is not provided, it is implied through the discussion of dosing adjustments 5
Many physicians may be unfamiliar with evidence-based target doses for heart failure and cardiovascular risk reduction, leading to failure to recognize target doses 5
Clinical inertia often leads to patients remaining on suboptimal doses despite tolerance of current dose, resulting in inadequate uptitration 5
Confusion with hypertension dosing and fear of adverse effects may also lead to reluctance to uptitrate ramipril 5